Processing

Please wait...

Settings

Settings

1. WO2015171725 - HYDRATE, CRYSTALLINE HYDRATE AND CRYSTALLINE ANHYDRATE FORMS OF N-((1S)-1-(7-FLUORO-2-(2-PYRIDINYL)-3-QUINOLINYL)ETHYL)-9H-PURIN-6-AMINE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHODS FOR TREATING CANCER.

Publication Number WO/2015/171725
Publication Date 12.11.2015
International Application No. PCT/US2015/029413
International Filing Date 06.05.2015
IPC
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
473
Heterocyclic compounds containing purine ring systems
26
with an oxygen, sulfur, or nitrogen atom directly attached in position 2 or 6, but not in both
32
Nitrogen atom
34
attached in position 6, e.g. adenine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519
ortho- or peri-condensed with heterocyclic rings
52
Purines, e.g. adenine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
C07D 473/34 (2006.01)
A61K 31/52 (2006.01)
A61P 35/00 (2006.01)
CPC
C07D 473/34
Applicants
  • AMGEN INC. [US/US]; One Amgen Center Drive Thousand Oaks, CA 91320-1799, US
Inventors
  • KELLY, Ron, C.; US
  • WORTMAN, Sarah; US
Agents
  • PERSON, Richard, V.; US
Priority Data
61/989,38306.05.2014US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) HYDRATE, CRYSTALLINE HYDRATE AND CRYSTALLINE ANHYDRATE FORMS OF N-((1S)-1-(7-FLUORO-2-(2-PYRIDINYL)-3-QUINOLINYL)ETHYL)-9H-PURIN-6-AMINE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHODS FOR TREATING CANCER.
(FR) FORMES HYDRATÉES, CRISTALLINES HYDRATÉES ET CRISTALLINES ANHYDRES DE LA N-((1S)-1-(7-FLUORO-2-(2-PYRIDINYL)-3-QUINOLINYL)ÉTHYL)-9H-PURINE-6-AMINE, COMPOSITIONS PHARMACEUTIQUES EN CONTENANT ET MÉTHODES DE TRAITEMENT DU CANCER
Abstract
(EN)
Provided herein are novel hydrate and anhydrate forms of N-((1S)-1-(7-fluoro-2-(2-pyridinyl)-3-quinolinyl)ethyl)-9H-purin-6-amine. Also provided herein are pharmaceutical compositions containing the forms, and methods for using such compositions for treating cancer.
(FR)
L'invention porte sur de nouvelles formes hydratées et anhydres de la N-((1S)-1-(7-fluoro-2-(2-pyridinyl)-3-quinolinyl)éthyl)-9H-purine-6-amine. L'invention concerne également des compositions pharmaceutiques contenant lesdites formes et des procédés d'utilisation de telles compositions pour traiter le cancer.
Latest bibliographic data on file with the International Bureau